INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
16/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Jessica G. McDonald Schwegman Lundberg & Woessner P.A.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations, namely, pharmaceutical preparations for histological and cytological tissue processing applications and reagents for medical and medical diagnostic purposes; diagnostic preparations for medical use; reagents containing primary antibodies for medical use; chemical reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic reagents; clinical medical reagents; reagents for immuno-histochemistry detection and in situ-hybridisation detection for medical use; double, triple or multiple in situ hybridisation probes for application of multiple antibodies or probes in the same staining procedure to a tissue section during IHC staining for medical, research or veterinary purposes; epitope retrieval solutions for medical use; enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic histological dye and stain solutions for medical use; dewaxing and wash buffers used with the aforementioned preparations for use in disease testing; diagnostic preparations for clinical or medical laboratory use
Classe 9
Diagnostic apparatus and instruments, not for medical purposes, including, apparatus for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; apparatus for detection of tissue and/or cell based samples not for medical purposes; recorded and downloadable software for identifying and diagnosing cancer and other diseases and processing digital images; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus; measuring apparatus used to identify and/or diagnose cancer and other diseases, not for medical use; diagnostic testing apparatus incorporating chemical reagents not for medical use
Classe 10
Apparatus for detection of tissue and/or cell based samples, all for medical purposes; histopathology instruments; haematology instruments for clinical purposes, namely tissue staining instruments; diagnostic medical apparatus for performing immunohistochemistry and in situ-hybridisation staining reactions, and histological and pathological staining; in situ hybridisation probes; apparatus for medical use promoting and controlling reaction on microarrays or under slide covertiles used in conjunction with histopathology instruments, tissue staining instruments and diagnostic medical apparatus for performing immunohistochemistry and in situ hybridisation staining reactions and histological and pathological staining; in-vitro diagnostic testing apparatus incorporating chemical reagents for medical use; medical specimen collection slides for specimen collection in surgery
Classe 42
[ Medical research; installation and integration of computer software, including within existing hospital and laboratory infrastructure; maintenance, updating and upgrading of software; all the aforementioned for use in connection with medical analysis, diagnosis and research ]
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
PARTIAL INVALIDATION PROCESSED BY THE IB
16/07/2026
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
16/06/2026
INVALIDATION PROCESSED
16/06/2026
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
18/11/2025
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2025
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/10/2025
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/10/2025
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2025
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2025
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/10/2025
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/10/2025
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
18/03/2025
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
18/03/2025
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/03/2025
TEAS SECTION 71 & 15 RECEIVED
08/10/2024
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/10/2023
FINAL DECISION TRANSACTION PROCESSED BY IB
08/02/2019
FINAL DISPOSITION NOTICE SENT TO IB
18/01/2019
FINAL DISPOSITION PROCESSED
18/01/2019
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/01/2019
REGISTERED-PRINCIPAL REGISTER
09/10/2018
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/09/2018
EXTENSION OF TIME TO OPPOSE RECEIVED
24/07/2018
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
16/07/2018
LIMITATION OF GOODS RECEIVED FROM IB
13/07/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/06/2018
PUBLISHED FOR OPPOSITION
26/06/2018
NOTIFICATION PROCESSED BY IB
23/06/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/06/2018
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/06/2018
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/06/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
24/05/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
24/05/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/05/2018
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/05/2018
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
13/03/2018
SUBSEQUENT FINAL EMAILED
13/03/2018
SUBSEQUENT FINAL REFUSAL WRITTEN
13/03/2018
NOTIFICATION OF FINAL REFUSAL EMAILED
07/02/2018
FINAL REFUSAL E-MAILED
07/02/2018
FINAL REFUSAL WRITTEN
07/02/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
19/01/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/01/2018
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/01/2018
ATTORNEY REVIEW COMPLETED
30/11/2017
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
15/11/2017
LIMITATION OF GOODS RECEIVED FROM IB
27/10/2017
REFUSAL PROCESSED BY IB
04/08/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/07/2017
REFUSAL PROCESSED BY MPU
20/07/2017
APPLICATION FILING RECEIPT MAILED
15/07/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/07/2017
NON-FINAL ACTION WRITTEN
13/07/2017
ASSIGNED TO EXAMINER
11/07/2017
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2017
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/07/2017
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.